Dr. Eileen Kennedy, Assistant Professor Presents…


Eileen Kennedy, Assistant Professor

Invited Oral Presentation, “Dissecting AKAP signaling complexes,” 4th International Workshop on cAMP signaling, PKA and phosphodiesterases, Erciyes University, Kayseri, Turkey, September 3-5, 2015

 

Y. George Zheng, Associate Professor, Serves as Ad Hoc Reviewer and Presents


Y. George Zheng, Associate Professor

Served as an ad hoc grant reviewer for National Science Foundation (NSF).

Served as an ad hoc grant reviewer for the Research Corporation for Science Advancement.

Served as an ad hoc grant reviewer for Research Grants Council (RGC) of Hong Kong.

Presented an invited talk titled “Isoform-Selective Inhibitors Targeting Protein Arginine Methyltransferases” at 2015 Chinese Medicinal Chemistry Symposium, at Lanzhou, China.

 

Dr. Aaron Beedle – Student Presentations at STaR Conference


Aaron Beedle, Assistant Professor

Student presentations at the 2015 STaR Conference in Athens, GA:

Foltz SJ, Patel A, Peissig KB and Beedle AM. Therapeutic targeting of aberrant AKT/mTOR signaling in Fktn-deficient muscle.

Fortunato MJ, Ball CE, Hollinger K, Patel NB, Modi JN, Rajasekaran V, Nonneman DJ, Ross JW, Kennedy EJ, Selsby JT and Beedle AM. Rabbit monoclonal antibodies for the detection of α-dystroglycan core protein.

Wang YM, Hekatyar SK, Foltz SJ and Beedle AM. Evaluation of MRI for phenotypic assessment in a mouse model of muscular dystrophy.

 

Mandi Murph, Associate Professor, Publishes


Mandi Murph, Associate Professor

Suppression of the GTPase-activating protein RGS10 increases Rheb-GTP and mTOR signaling in ovarian cancer cells.

Altman MK, Alshamrani AA, Jia W, Nguyen HT, Fambrough JM, Tran SK, Patel MB, Hoseinzadeh P, Beedle AM, Murph MM.

Cancer Lett. 2015 Aug 28. pii: S0304-3835(15)00541-8. doi: 10.1016/j.canlet.2015.08.012. [Epub ahead of print] PMID: 26319900

 

Dr. Gurvinder Singh Rekhi, Academic Faculty Assoc., Issued Two Patents


Gurvinder Singh Rekhi, Academic Faculty Associate

US patent issued for “Controlled Release Compositions Comprising a Combination of Isosorbide Dinitrate and Hydralazine

Hydrochloride”. US 8,992,973 B2 March 31, 2015. Inventors – Gurvinder Singh Rekhi, Richard Sidwell and Sharon Hamm

US patent issued for “Abuse Resistant Pharmaceutical Compositions”. US 9,132,096 B1 September 15, 2015. Inventors –Gurvinder Singh Rekhi and Richard Sidwell.